Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study.

Arvid EngströmViktor WintzellMads MelbyeAnders HviidBjörn EliassonSoffia GudbjörnsdottirKristian HveemChristian JonassonHenrik SvanströmBjörn PasternakPeter Ueda

Published in: Diabetes care (2022)

In this cohort study using nationwide data from three countries, use of SGLT2 inhibitors, compared with GLP-1 receptor agonists, was associated with a modestly reduced risk of new-onset AF.

Keyphrases

atrial fibrillation
left atrial
electronic health record
heart failure
catheter ablation
direct oral anticoagulants
big data
percutaneous coronary intervention
machine learning
coronary artery disease
deep learning
mitral valve
acute coronary syndrome